Nanologica AB
SEK5.7
2
+SEK0+0% Friday 14:21
Statistics
Day High
5.7
Day Low
5.56
52W High
12.7
52W Low
4.49
Volume
10,914
Avg. Volume
23,109
Mkt Cap
250.93M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
16MayExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NICA.ST. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Waters
WAT
Mkt Cap17.96B
Agilent Technologies
A
Mkt Cap38.45B
Thermo Fisher Scientific
TMO
Mkt Cap203.97B
Bruker
BRKR
Mkt Cap8.99B
Bio-Rad Laboratories
BIO
Mkt Cap8.45B
Danaher
DHR
Mkt Cap180.39B
Mettler-Toledo International
MTD
Mkt Cap28.71B
About
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA HPLC analytical columns. The company provides products for the analysis and purification of substances, with a focus on peptides and diabetes drugs. In addition, it is involved in the development of nanoporous amorphous particles (NAP), a platform technology for inhalation to give access to new or enhanced treatments for the patients with severe lung diseases. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
Show more...
CEO
Mr. Andreas Bhagwani
Employees
16
Country
SE
ISIN
SE0005454873
WKN
000A2P5V2